JVMCX | PMVQX | JVMCX / PMVQX | |
Total Expense Ratio | 1.87 | 0.73 | 256% |
Annual Report Gross Expense Ratio | 1.88 | 0.88 | 214% |
Fund Existence | 14 years | 15 years | - |
Gain YTD | 8.340 | 5.607 | 149% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 23.6B | 163M | 14,479% |
Annual Yield % from dividends | 0.00 | 1.76 | - |
Returns for 1 year | -0.87 | 8.96 | -10% |
Returns for 3 years | 8.57 | 18.90 | 45% |
Returns for 5 years | 43.38 | 92.52 | 47% |
Returns for 10 years | 32.89 | 43.08 | 76% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HGHIX | 36.34 | 0.54 | +1.51% |
Hartford Healthcare I | |||
FCGPX | 20.78 | 0.04 | +0.19% |
NYLI PineStone Global Equity Class P | |||
SUVZX | 13.18 | -0.05 | -0.38% |
PGIM Quant Solutions Large-Cap Val Z | |||
PASVX | 53.27 | -0.23 | -0.43% |
T. Rowe Price Small-Cap Value Adv | |||
JORSX | 16.29 | -0.10 | -0.61% |
JHancock Small Cap Core R6 |